23486032 Comparative Analysis Breakdown

    23486032 -- Ireland Fund  

    EUR 10.12  0.16  0.02%

    You can use this module to analyze advantages of 23486032 technical and fundamental indicators over its peers. Please use the box above to enter up to 4 concurrent symbols you would like to analyze. Use comma (,) to separate each symbol. With this comparative module your can estimate the relative strength of 23486032 against its competitors. Check also Trending Equities.

        
     Better Than Average     
        
     Worse Than Peers or Benchmark    View Performance Chart
    23486032IE00B3FH9W18IE00BFRTD946IE0032915336IE0033246004IE00B7FN4H78
    0.16  0.02
     10.12 
    23486032
    166.84  0.08
     2,165 
    Polar Capital
    11,089  0.99
     113.24 
    Vanguard Japan
    4.13  0.03
     149.77 
    Vanguard Japan
    0.00  0.00
     1.00 
    GS USD
    1,201  0.99
     12.55 
    Neuberger Berman
    Market Performance
    (Over the last 30 days)
    0
    0
    14
    7
    0
    14
    Chance of Financial Distress
    (Probability Of Bankruptcy)
    50%
    1%
    2%
    1%
    1%
    2%
    Net Asset
    Minimum Initial Investment
    Five Year Return
    One Year Return
    Last Dividend Paid
    Price to Sales
    Price to Book
    Equity Positions Weight
    Cash Position Weight
    Three Year Return
    Bond Positions Weight
    Ten Year Return
    Price to Earning
    Coefficient Of Variation
    Mean Deviation
    Jensen Alpha
    Total Risk Alpha
    Sortino Ratio
    Downside Variance
    Standard Deviation
    Kurtosis
    Potential Upside
    Treynor Ratio
    Maximum Drawdown
    Variance
    Market Risk Adjusted Performance
    Risk Adjusted Performance
    Skewness
    Semi Deviation
    Information Ratio
    Value At Risk
    Expected Short fall
    Downside Deviation
    Semi Variance

    Did You Try This Idea?

    Run Drugs Thematic Idea Now

    Drugs
    Drugs Idea
    Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Drugs theme has 30 constituents.
    View All  Next Launch Drugs
    Check also Trending Equities. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
    Search macroaxis.com